福森药业有限公司（01652）于2026年3月3日发布2026年2月股份变动月报表。报告显示，截至2026年2月28日，公司注册股本维持在2,000,000,000股，每股面值为0.01港元，总额20,000,000港元，未发生变动。
已发行股份方面，截至2月底仍为739,301,000股；报告期内无新增发行、购回或注销活动，库存股份数目维持为零。此外，关于2018年6月14日授出的购股权计划，本月并无行权或转让活动，期末未行使期权仍为16,000,000股。
公司在公告中确认依照香港联交所相关规定保持足够的公众持股量，并遵守了上市规则及法律法规要求。截至2月底，公司股本构成与上月相比未有任何变动。该公告由公司秘书杨育康签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.